From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...
Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...
Which is why, in part, the promise — and boom — of blood biomarkers testing has moved quickly in the past three to five years, researchers say. The FDA recently cleared two blood tests that detect ...
A nationwide survey by the Alzheimer’s Association in 2025 found close to 4 in 5 Americans 45 and older want to know if they have Alzheimer’s before symptoms appear. And 91% said they would take a ...
May 16 (UPI) --The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in patients beginning to show cognitive decline. Fujirebio ...
A new blood test for Alzheimer’s disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can ...
A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...
That blood test your doctor suggested to check for Alzheimer’s? It might be giving dramatically different results depending on your race. While these tests promise earlier detection of a devastating ...
Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...
Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental impact ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results